TONIX PHARMACEUTICALS HOLDING CORP. Cash
TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) had Cash of $58.18 million as of 2015-03-31, per its 10-Q filed 2015-05-08.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:Cash · last filed 2015-05-08
- 2015-03-31: Cash $58.18M.
- 2014-12-31: Cash $38.18M.
- 2014-09-30: Cash $46.23M.
- 2014-06-30: Cash $43.87M.
| Period end | Cash | Cash as first filed |
|---|---|---|
| 2015-03-31 | $58.18M 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $38.18M 10-Q · filed 2015-05-08 | |
| 2014-09-30 | $46.23M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $43.87M 10-Q · filed 2014-08-08 | |
| 2014-03-31 | $49.55M 10-Q · filed 2015-05-08 | |
| 2013-12-31 | $8.20M 10-Q · filed 2015-05-08 | |
| 2013-09-30 | $7.42M 10-Q · filed 2014-11-07 | $7.42M 10-Q · filed 2013-11-13 |
| 2013-06-30 | $68.00K 10-Q · filed 2014-08-08 | $68.04K 10-Q · filed 2013-08-14 |
| 2013-03-31 | $424.00K 10-Q · filed 2014-05-13 | $423.74K 10-Q · filed 2013-05-07 |
| 2012-12-31 | $1.78M 10-K · filed 2015-02-27 | $1.79M 10-K · filed 2013-03-11 |
| 2012-09-30 | $35.65K 10-Q · filed 2013-11-13 | |
| 2012-06-30 | $1.34M 10-Q · filed 2013-08-14 | |
| 2012-03-31 | $2.50M 10-Q · filed 2013-05-07 | |
| 2011-12-31 | $41.00K 10-K · filed 2014-03-28 | $41.12K 10-K · filed 2012-03-30 |
| 2011-09-30 | $6.83K 10-K · filed 2013-03-11 | $205.00 10-Q · filed 2011-10-07 |
| 2011-06-30 | $21.34K 10-Q · filed 2012-08-13 | $747.00 10-Q · filed 2011-08-15 |
| 2011-03-31 | $2.36K 10-Q · filed 2012-05-15 | |
| 2010-12-31 | $65.36K 10-K/A · filed 2013-11-22 | $4.62K 10-Q · filed 2011-08-15 |
| 2010-09-30 | $4.08K 10-Q · filed 2011-10-07 | |
| 2010-06-30 | $4.12K 10-Q · filed 2011-08-15 | |
| 2009-12-31 | $1.06K 10-K · filed 2012-03-30 | $12.61K 10-Q · filed 2011-08-15 |
| 2007-11-15 | $0.00 10-Q · filed 2011-10-07 | |
| 2007-06-07 | $0.00 10-K · filed 2014-03-28 | |
| 2007-06-06 | $0.00 10-Q · filed 2014-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |